🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 8/5/2026 · $17.00/share
Business: Attovia Therapeutics, Inc is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases using the ATTOBODY platform. The ATTOBODY platform uses an evolution-driven, high-throughput process which allows for rapid discovery and creation of a high diversity of potential product candidates.
Company Contact
- CEO
- Tao Fu
- CFO
- Steven Chan
- Headquarters
- 1091 Industrial Road, Suite 310, San Carlos, CA 94070
- Phone
- 510-399-5001
- Investor Relations
- PJ Kelleher, LifeSci Advisors · 617-430-7579 · pkelleher@lifesciadvisors.com